Atıf İçin Kopyala
Çengelli Ünel Ç., Dönertaş B., Aydin Ş., Ulupinar E., Özatik O., Kaygisiz B., ...Daha Fazla
TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.51, sa.6, ss.3098-3107, 2021 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
51
Sayı:
6
-
Basım Tarihi:
2021
-
Doi Numarası:
10.3906/sag-2101-224
-
Dergi Adı:
TURKISH JOURNAL OF MEDICAL SCIENCES
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.3098-3107
-
Anahtar Kelimeler:
Cis-diamminedichloroplatinum(II), n-arachidonoylethanolamide, ng nitroarginine methyl ester, nitric oxide, peripheral neuropathy, ROOT GANGLION NEURONS, ACID AMIDE HYDROLASE, NITRIC-OXIDE, CANNABINOID RECEPTOR, SCIATIC-NERVE, REDUCES PAIN, NEUROTOXICITY, HYPERALGESIA, INHIBITION, MODEL
-
Eskişehir Osmangazi Üniversitesi Adresli:
Evet
Özet
Background/aim: Cisplatin (CIS) is an effective antineoplastic agent used in the treatment of several cancer types. Peripheral neuropathy is a major dose-limiting side-effect in CIS therapy. Cannabinoids may alleviate this painful side effect. This study investigated the analgesic effects of anandamide (AN) on CIS-induced peripheral neuropathy, in vitro effects of AN in CIS neurotoxicity, and the contribution of nitric oxide (NO) in this effect.